Recent developments on therapeutic and diagnostic approaches for COVID-19
J Majumder, T Minko - The AAPS journal, 2021 - Springer
The ongoing pandemic of coronavirus disease 2019 (COVID-19) caused by the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has made a serious public health …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has made a serious public health …
A systematic review of the global intervention for SARS-CoV-2 combating: from drugs repurposing to molnupiravir approval
NA Ashour, A Abo Elmaaty, AA Sarhan… - Drug design …, 2023 - Taylor & Francis
The rising outbreak of SARS-CoV-2 continues to unfold all over the world. The development
of novel effective antiviral drugs to fight against SARS-CoV-2 is a time cost. As a result, some …
of novel effective antiviral drugs to fight against SARS-CoV-2 is a time cost. As a result, some …
A comparative analysis for anti-viral drugs: Their efficiency against SARS-CoV-2
Coronavirus, known as the coronavirus pandemic, is continuing its spread across the world,
with over 42 million confirmed cases in 189 countries and more than 1.15 million deaths …
with over 42 million confirmed cases in 189 countries and more than 1.15 million deaths …
Molecular docking and dynamics studies of Nicotinamide Riboside as a potential multi-target nutraceutical against SARS-CoV-2 entry, replication, and transcription: A …
Z Esam, M Akhavan, A Bekhradnia - Journal of molecular structure, 2022 - Elsevier
Abstract The highly contagious Coronavirus Disease 2019 (COVID-19) caused by Severe
Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which is a newborn infectious …
Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which is a newborn infectious …
[HTML][HTML] Repurposing FDA-approved drugs cetilistat, abiraterone, diiodohydroxyquinoline, bexarotene, and Remdesivir as potential inhibitors against RNA dependent …
Vaccines are undoubtedly the most effective means of combating viral diseases like COVID-
19. However, there are risks associated with vaccination, such as incomplete viral …
19. However, there are risks associated with vaccination, such as incomplete viral …
The ineluctable role of ACE-2 receptors in SARS COV-2 infection and drug repurposing as a plausible SARS COV-2 therapy: a concise treatise
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiological agent for
the COVID-19 infectious disease that spreads via the respiratory route and has reached a …
the COVID-19 infectious disease that spreads via the respiratory route and has reached a …
COWAVE: A labelled COVID-19 wave dataset for building predictive models
M Pradeep, K Raman - Plos one, 2023 - journals.plos.org
The ongoing COVID-19 pandemic has posed a significant global challenge to healthcare
systems. Every country has seen multiple waves of this disease, placing a considerable …
systems. Every country has seen multiple waves of this disease, placing a considerable …
Does the number of publications matter for academic promotion in higher education? Evidence from Lebanon
This paper uses unique data from Lebanon to explore the factors affecting promotion in
academia. We use the Ordered Probit model to answer the research question empirically …
academia. We use the Ordered Probit model to answer the research question empirically …
Navigating the crisis: A review of COVID-19 research and the importance of academic publications-The case of a private university in Lebanon
N Khaddage-Soboh, S Tawil - Heliyon, 2023 - cell.com
Objectives The threat of the Corona virus has had a profound global impact, prompting
extensive discussions among academicians and medical researchers seeking to …
extensive discussions among academicians and medical researchers seeking to …
Deciphering the therapeutical potentials of rosmarinic acid
Lemon balm is herbal tea used for soothing stomach cramps, indigestion, and nausea.
Rosmarinic acid (RA) is one of its chemical constituents known for its therapeutic potentials …
Rosmarinic acid (RA) is one of its chemical constituents known for its therapeutic potentials …